Skip to content
Menu

Heartflow, Inc. HTFL

Full chart Compare
Set alert

Price alert · HTFL

All alert types
44.63 USD -1.26 (-2.75%)

Regular-session close

44.41 -0.22 -0.49%

After hours · Nov 19, 7:50 PM ET

44.38 Day range 47.51
20.13 52-week range 60.66
YTD
+53.10%
1 year
+63.90%

5D -10.29 (-18.75%)

455055FriMonTueWedThu44.58
Market cap
3.92B
Revenue (ttm)
238.66M
Profit margin
-33.11%
EPS (ttm)
0.65
Shares out
87.89M
P/E ratio
68.66
Forward P/E
-168.31
YTD return
+53.10%
1-year return
+63.90%
Volume
1.28M
Avg volume
1.86M
Open
46.57
Previous close
45.89
Day's range
44.38 – 47.51
52-week range
20.13 – 60.66
Analysts
Strong Buy
Price target
65.00 (+45.6%)
Earnings date
Mar 17, 2027

Key statistics

50-day average
51.84
200-day average
35.47
Enterprise value
3.89B
Price / sales
16.44
Price / book
13.87
Revenue growth
57.40%
Free cash flow
-32.03M
Total cash
167.74M
Total debt
25.93M
Return on equity
-29.43%
Short % of float
9.33%

Fundamental scorecard

6 of 25 checks passed on HTFL’s reported financials

ValueGrowthProfitabilityHealthDividend

6of 25 checks passed

  • Value 0 of 5
  • Growth 2 of 5
  • Profitability 1 of 5
  • Financial health 3 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
HTFL Revenue — quarterly 72.86M
HTFL Net income — quarterly -11.51M
HTFL EPS — quarterly -0.13

Earnings

HTFL recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Mar 17, 2027Dec 30, 2026-0.09———
Nov 12, 2026Sep 30, 2026-0.1029-0.03+0.07+70.85%
Aug 13, 2026Jun 30, 2026-0.13369-0.07+0.06+47.64%
May 14, 2026Mar 31, 2026-0.18763-0.16+0.03+14.73%
Mar 18, 2026Dec 31, 2025-0.18763-0.12+0.07+36.04%
Nov 12, 2025Sep 30, 2025-0.20-0.27-0.07-35.00%

Upgrades / downgrades

HTFL analyst upgrades and downgrades
DateFirmActionFromTo
Oct 20, 2026Piper SandlerreitOverweightOverweight
Sep 22, 2026Canaccord GenuitymainBuyBuy
Sep 9, 2026UBSinit—Neutral
Aug 14, 2026Canaccord GenuitymainBuyBuy
Aug 14, 2026Morgan StanleymainEqual-WeightEqual-Weight
Aug 14, 2026Piper SandlerreitOverweightOverweight

About Heartflow, Inc.

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company provides Heartflow RoadMap Analysis that offers an intuitive anatomic visualization of the coronary arteries; Heartflow FFRCT Analysis, which calculates blood flow and pinpoints clinically; and Heartflow Plaque Analysis that provides a comprehensive assessment of coronary plaque, enabling optimized medical treatment strategies. Its platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. HeartFlow, Inc. was formerly known as Cardiovascular Simulation, Inc. and changed its name to HeartFlow, Inc. in May 2009. The company was incorporated in 2007 and is headquartered in San Francisco, California.

Sector
Healthcare
Industry
Health Information Services
Country
United States

News

Your note

Sign in to keep a note on HTFL — it syncs with the Stock Master app.

Insider holders

HTFL insider holders
InsiderRelationLatest transactionDateShares held
BAIN CAPITAL LIFE SCIENCES INVESTORS, L.L.C.Beneficial Owner of more than 10% of a Class of SecuritySaleApr 29, 20260
BARABE TIMOTHY CRAIGDirectorConversion of Exercise of derivative securityJul 21, 2026188,231
FARQUHAR JOHN C. M.Chief Executive OfficerConversion of Exercise of derivative securityNov 9, 2026251,983
HEALTHCOR PARTNERS MANAGEMENT L.P.Beneficial Owner of more than 10% of a Class of SecurityConversion of Exercise of derivative securityAug 10, 20250
JONES MARIE LOfficerStock Award(Grant)Sep 7, 202632,403
LIGHTCAP JEFFREY CDirectorConversion of Exercise of derivative securityJul 23, 20266,991,240

Institution ownership

HTFL institution ownership
Holder% heldSharesValueReported
Blackrock Inc.6.87%6,040,943269.61MSep 29, 2026
Wellington Management Group, LLP6.31%5,548,202247.62MSep 29, 2026
FMR, LLC6.25%5,491,275245.08MSep 29, 2026
Bain Capital Life Sciences Investors, LLC5.06%4,448,158198.52MSep 29, 2026
Vanguard Portfolio Management LLC4.23%3,719,472166.00MSep 29, 2026
Vanguard Capital Management LLC3.77%3,315,690147.98MSep 29, 2026

Fund ownership

HTFL fund ownership
Holder% heldSharesValueReported
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund6.59%5,795,579258.66MJul 30, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.81%2,467,177110.11MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.26%1,987,44288.70MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.03%1,781,44079.51MJun 29, 2026
BARON INVESTMENT Fd.S TRT -BARON DISCOVERY Fd.1.83%1,604,89471.63MJun 29, 2026
AIM Counselor Series TRT -Invesco Discovery Fd.1.45%1,275,22556.91MAug 30, 2026